← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:901 | 901 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:901 | 901 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:901 | 901 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:901 | 901 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Racepinephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0850 | 5446-0850-10 | Lidocaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-313 | 70092-313-50 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-051 | 73198-051-30 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:901 | 901 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-30 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5614 | 26436-5614-1 | Naltrexone Hydrochloride Dihydrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:901 | 901 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:901 | 901 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:902 | 902 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-366 | 73693-366-01 | TESTOSTERONE, TRIAMCINOLONE 62.5MG, 12.5MCG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Racepinephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83343-006 | 83343-006-30 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:902 | 902 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:902 | 902 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:903 | 903 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6092 | 72196-6092-1 | Phenylephrine 40mg added to NS | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Racepinephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-946 | 69374-946-04 | Labetalol Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-2 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2421 | 72627-2421-1 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0217 | 72196-0217-1 | Magnesium Chloride; Dextrose Monohydrate; Lidocaine Hydrochloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-02 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:903 | 903 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2454 | 72627-2454-2 | Nicotinamide Adenine Dinucleotide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:903 | 903 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:904 | 904 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-224 | 71170-224-50 | Vancomycin 2.5g added to 500mL of 0.9% Sodium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4025 | 73271-4025-1 | Lidocaine Hydrochloride; Triamcinolone Acetonide | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-128 | 70092-128-50 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate Heptahydrate; Copper Gluconate; Manganese Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-05 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-161 | 82396-161-05 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:904 | 904 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:904 | 904 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-348 | 83298-348-10 | Norepinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:905 | 905 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-1 | Methione 25mg/Inositol 50mg/Choline 50mg/ml 30mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-35 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:905 | 905 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:905 | 905 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-117 | 69194-117-10 | Norepinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:906 | 906 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-617 | 70092-617-46 | Epinephrine 10 mcg/ml in 10 ml D5W syr | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1235 | 5446-1235-01 | Lidocaine; Benzocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0215 | 72196-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-519 | 70092-519-48 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:906 | 906 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-501 | 82396-501-10 | Nicotinamide Adenine Dinucleotide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:906 | 906 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:907 | 907 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine 8MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:907 | 907 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:907 | 907 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:907 | 907 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:907 | 907 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-126 | 70092-126-49 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-3 | Mitomycin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5055 | 26436-5055-3 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0112 | 72196-0112-1 | Magnesium Sulfate Heptahydrate; Tromethamine; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Magnesium Chloride; Sodium Acetate; Potassium Chloride; Mannitol | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-380 | 70092-380-36 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:907 | 907 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-500 | 82396-500-01 | Nicotinamide Adenine Dinucleotide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:907 | 907 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:908 | 908 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-110 | 73702-110-10 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1022 | 71283-1022-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-725 | 70004-725-09 | Lidocaine Hydrochloride Anhydrous | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:908 | 908 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Bupivacaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:908 | 908 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:908 | 908 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-315 | 70092-315-74 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:908 | 908 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5194 | 26436-5194-3 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-518 | 70092-518-75 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-161 | 82396-161-05 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-35 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:908 | 908 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-146 | 73702-146-61 | Nicotinamide Riboside Chloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:908 | 908 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:909 | 909 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2425 | 72627-2425-1 | Taurine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:909 | 909 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-728 | 70004-728-12 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:909 | 909 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1548 | 5446-1548-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:909 | 909 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Leflunomide | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:909 | 909 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-3 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:909 | 909 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:909 | 909 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:910 | 910 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:910 | 910 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:910 | 910 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:910 | 910 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1543 | 5446-1543-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-145 | 63037-145-25 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-8 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0205 | 72196-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:910 | 910 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:910 | 910 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5026 | 71266-5026-2 | Norepinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:911 | 911 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:911 | 911 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:911 | 911 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:911 | 911 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Glutamine; Ornithine; Lysine Hydrochloride; Arginine; Citrulline | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1480 | 5446-1480-01 | Lidocaine; Hyaluronidase; Racepinephrine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:911 | 911 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-613 | 70092-613-79 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-521 | 70092-521-74 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:911 | 911 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5016 | 71266-5016-2 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:911 | 911 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-3 | Nystatin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:912 | 912 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:912 | 912 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0990 | 71283-0990-6 | Lidocaine Hydrochloride; Hyaluronic Acid | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1256 | 5446-1256-01 | Lidocaine; Oxymetazoline Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:912 | 912 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:912 | 912 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-127 | 70092-127-35 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:912 | 912 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1223 | 70657-1223-3 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-505 | 81375-505-01 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:912 | 912 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5026 | 71266-5026-2 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:912 | 912 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-127 | 73198-127-30 | Ondansetron Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:913 | 913 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1440 | 72934-1440-1 | LOUNZDOMDIOXIATAR | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:913 | 913 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-07 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0990 | 71283-0990-2 | Lidocaine Hydrochloride; Hyaluronic Acid | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1045 | 5446-1045-03 | Lidocaine; Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2415 | 72627-2415-1 | Levocarnitine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:913 | 913 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-02 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-519 | 70092-519-48 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 |